Idiopathic Retroperitoneal Fibrosis Clinical Trials

7 clinical trials for Idiopathic Retroperitoneal Fibrosis across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis — RECRUITING · PHASE4
• National Registry of IRPF in China — RECRUITING
• A Prospective Cohort Study of IRPF in China — RECRUITING
• METRO Early discontinuation of steroid treatment in negative FDG-PET/CT patients with idiopathic retroperitoneal fibrosis. A prospective multicentric study — TERMINATED · PHASE4
• A Prospective Study of Tocilizumab in the Treatment of Idiopathic Retroperitoneal Fibrosis — OTHER · PHASE4
• A Prospective Study of Cyclophosphamide Treatment for Idiopathic Retroperitoneal Fibrosis — OTHER · PHASE4
• Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Trial — OTHER · PHASE3

Refine this search